Track the Laboratorios Farmaceuticos Rovi, S.A. share price and the full insider trade history of the company, a listed issuer based in Spain. Shares trade on ES ES, under the authority of CNMV. Operating in the Health Care sector, Laboratorios Farmaceuticos Rovi, S.A. has logged 13 reports. Market capitalisation: €3bn. The latest transaction was filed on 23 June 2023 (Purchase). Among the most active insiders: Javier López-Belmonte Encina. All data is free.
13
Insider Decl.
0
Thresholds
€2m
2 ops.
Buy Volume
€161m
6 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Laboratorios Farmaceuticos Rovi, S.A. Buy (bullish), based on 9 analysts. Average price target: €82.30.
25Σ signal
Buys €2m€161m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 5,371 of 26,034 companies
66.4
score / 100
Value
51
Quality
82
FCF yld2.6%
Earn yld4.6%
EV/EBITDA14.8x
ROE20%
Gross mgn63%
Net mgn18%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.